TF and thymus atrophy: On the other hand, pre-experimental verification showed that this dose can induce typical REV pathogenic effects such as growth inhibition and thymic atrophy, with an acute mortality rate of <20%, which not only ensures the stability of the infection model but also avoids the interference of high mortality on the evaluation of TF’s intervention effect.